Author

Deepa Nakmode

Institutions: Adelaide University, The University of Adelaide

Observed institutions: Biocon (India), National Institute of Pharmaceutical Education and Research, National Institute of Pharmaceutical Education and Research, Adelaide University, The University of Adelaide

ORCID: 0000-0003-3207-1236

Observed ORCID: 0000-0003-3207-1236

OpenAlex ID: A5023534012

Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development

2022 · Deepa Nakmode, Valamla Bhavana, et al. · Pharmaceutics · 91

Design, Structure–Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-b]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors

2023 · Richard A. Hartz, Vijay T. Ahuja, et al. · Journal of Medicinal Chemistry · 38

Discovery of 2-(Anilino)pyrimidine-4-carboxamides as Highly Potent, Selective, and Orally Active Glycogen Synthase Kinase-3 (GSK-3) Inhibitors

2023 · Richard A. Hartz, Vijay T. Ahuja, et al. · Journal of Medicinal Chemistry · 26

PLGA-Phospholipid Hybrid Oleogel In Situ Forming Implant for Sustained 30-Day Co-Delivery of Donepezil and Memantine

2026 · Baljinder Singh, Weranga Rajapaksha, et al. · AAPS PharmSciTech

Engineering long-acting injectable in situ forming implants for sustained delivery of citalopram in depression management

2026 · Haripriya Koppisetti, Deepa Nakmode, et al. · Drug Delivery and Translational Research

Works count: 5

Citation count: 155

H-index: 3

I10-index: 3